Discovering Hope.
Every Day.

The Largest Phase 0 Clinical Trials Program in the World
The Ivy Brain Tumor Center is a nonprofit translational research program that offers state-of-the-art clinical trials for patients with even the most aggressive brain tumors.
Individualized Treatment in a Fraction of the Time
When a brain tumor patient is referred to an Ivy Phase 0 clinical trial, we partner with their physicians and treatment team on a path forward.
Programs in Place for Rapid Clinical Testing
Partner with the nation's largest operative brain tumor program that's employing a bold, early-phase clinical trials strategy to rapidly identify new effective therapies.
Drug Delivery
Innovative technique aims to bypass the blood-brain barrier
The Ivy Center announced the initiation of a ground-breaking Phase 0 clinical trial that tests a new experimental drug delivery method called superselective intra-arterial infusion, or SSIAI.
Building on
New Global Headquarters
The Ivy Brain Tumor Center is well underway on the construction of its new headquarters, the world’s largest translational research center dedicated solely to brain tumor drug development and treatment.

Phase 0 Trials

Ivy Phase 0 clinical trials allow patients to receive individualized treatment in a fraction of the time and costs associated with traditional drug research and development.

Benefits of an Ivy Phase 0 Trial

Saves Valuable Time

Time tracking icon

Drug effects on a patient’s tumor are directly measured within 10 days of surgery. If an experimental regimen is ineffective, the patient can transition to another type of therapy without losing time or options.

Personalizes Treatment

DNA icon

Genetic testing with unprecedented depth allows us to match tumors to new combination drug regimens. Due to the speed in which our trials open and close, we are able to test more new therapies than any other clinical trials program. 

Tests New Drugs

Medicine Icon

Every Ivy Center drug combination tests new mechanisms never before trialed in brain tumor patients.  As a nonprofit organization, there is no conflict of interest or hidden agenda in selecting which drugs to include in our program.

Dr. Patricia Tagle-Levy


Patricia: Clinical Trial Patient

When Patricia’s glioblastoma came back after her first surgery, she and her husband both knew it was time to start looking at alternative treatment options. After extensive research, they discovered the hope they were looking for was actually right in their backyard at the Ivy Center in Phoenix.

Read Full Story


Team stacking hands to show teamwork
Read More
Ivy Blog
Making a Difference on Glioblastoma Awareness Day 2023

Glioblastoma Awareness Day (GBM Day) is dedicated to increasing public awareness of glioblastoma brain cancer.

woman wearing a bandana and holding a mug

Am I Eligible?

Submit a Trial Screening Request today and an Ivy Navigator will contact you within 48 hours to complete the initial patient assessment.

Determine your Eligibility